Plunkett Research Online: ImmunoGen Inc

IMMUNOGEN INC (IMGN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ImmunoGen, Inc. is a clinical-stage biotechnology company engaged in the development of next-generation antibody-drug conjugates (ADCs). An ADC with the firm’s proprietary technology comprises an antibody that binds to a target found on tumor cells and is conjugated to one of ImmunoGen’s potent ant.....



ImmunoGen Inc
Ticker: IMGN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 781 895-0600
Fax:
Address: 830 Winter Street
Waltham, MA 02451 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Anticancer Biopharmaceuticals
Drugs-Oncology
ContactsDescription

Mark EnyedyCEO/CFO/Director/President
Stephen MccluskiChairman of the Board/Director
See More
ImmunoGen, Inc. is a clinical-stage biotechnology company engaged in the development of next-generation antibody-drug conjugates (ADCs). An ADC with the firm’s proprietary technology comprises an antibody that binds to a target found on tumor cells and is conjugated to one of ImmunoGen’s potent ant.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201820172016201620152014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Mirvetuximab soravtansine
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors:

The company offers its employees health and dental coverage, life and AD&D insurance, a 401(k) plan, tuition reimbursement and stock options.